Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00293631 · ClinicalTrials.gov registry record · Phase 2
Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After Bunionectomy
A Phase 2 study, sponsored by POZEN.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT00293631 is a Phase 2 study that has completed, run by POZEN. The registered enrollment target is 100 participants.
The verdict
NCT00293631, a Phase 2 study, has completed, sponsored by POZEN.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
To determine whether a single dose of intravenous lornoxicam is superior to intravenous placebo for management of post-operative pain in patients who have surgical removal of a bunion on the lower extremity. One-fourth of patients in this study will receive a single dose of intravenous ketorolac for management of pain and one-fourth of patients in this study will receive a single dose of an intravenous placebo.
Interventions
- DRUG Placebo
- DRUG Lornoxicam 8 mg
- DRUG Lornoxicam 16 mg
- DRUG Ketorolac 30 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2005-11 |
| Est. Completion | 2006-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00293631
The ClinicalTrials.gov registry entry for NCT00293631 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is POZEN, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00293631 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00293631 about?
NCT00293631 is a clinical study titled "Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After Bunionectomy". To determine whether a single dose of intravenous lornoxicam is superior to intravenous placebo for management of post-operative pain in patients who have surgical removal of a bunion on the lower extremity. One-fourth of patients in this study will receive a single dose of intravenous ketorolac for...
What is the current status of trial NCT00293631?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2005-11. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00293631?
The interventions under investigation include: Placebo (DRUG), Lornoxicam 8 mg (DRUG), Lornoxicam 16 mg (DRUG), Ketorolac 30 mg (DRUG).
Who is sponsoring clinical trial NCT00293631?
This trial is sponsored by POZEN, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.